Investing.com -- Barclays upgraded Croda International to Overweight from Equal Weight, saying activist investor involvement and cost-cutting plans could help turn around the specialty chemicals group after a sharp share price slide in recent years. Barclays said the entry of activist fund Standard Latitude could mark a “potential turning point,” as it brings pressure for strategic changes, including divestments. It set a new price target of 3,100 pence, down from 3,600 pence earlier. The brokerage described the lipid market as likely oversupplied and said the unit could be a target for activist action or value realisation. Related articlesBarclays upgrades Croda on activist investor, cost cutting plansSilver: Global Markets Show Signs of a Gold-Like Bullish Run With $44 in SightLoading Up HEAVY on These 3 Stocks by End of 2025 (+ 1 New ETF)